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OBJECTIVE We sought to conduct a randomized trial comparing late revascularization with conservative
therapy in symptom-free patients after acute myocardial infarction (AMI).
BACKGROUND In the absence of ischemia, the benefits of reperfusion late after AMI remain controversial.
However, the possibility exists that an open infarct related artery benefits healing post AMI.
METHODS Of 223 patients enrolled with Q-wave anterior AMI, 66 with isolated persistent occlusion of
the left anterior descending coronary artery (LAD) were randomized to the following
treatments: 1) medical therapy (closed artery group; n  34) or 2) late intervention and stent
to the LAD  medical therapy (open artery group; n  32). The study was powered to
compare left ventricular (LV) end-systolic volume between the two groups 12 months post
AMI.
RESULTS Late intervention 26 18 days post AMI resulted in significantly greater LV end-systolic and
end-diastolic volumes at 12 months than medical therapy alone (106.6  37.5 ml vs. 79.7 
34.4 ml, p 0.01 and 162.0 51.4 ml vs. 130.1 46.1 ml, p 0.01, respectively). Exercise
duration and peak workload significantly increased in both groups from 6 weeks to 12 months
post AMI, although absolute values were greater in the open artery group. Quality of life
scores tended to deteriorate during this time interval in the closed artery patients but
remained unchanged in the open artery patients. Coronary angiography at 1 year documented
a low incidence of intergroup cross-over (spontaneous recanalization in 19% and closure in
11%).
CONCLUSIONS In the present study, recanalization of occluded infarct-related arteries in symptom-free
patients approximately 1 month post AMI had an adverse effect on remodeling but tended to
increase exercise tolerance and improve quality of life. (J Am Coll Cardiol 2002;40:869–76)
© 2002 by the American College of Cardiology Foundation
The benefits of early reperfusion in acute myocardial infarc-
tion (MI) involve infarct size reduction, preservation of left
ventricular (LV) function, and increased survival (1). By
contrast, the role of late reperfusion, beyond the window for
myocardial salvage, remains controversial. The potential
mechanisms of benefit attributable to late reperfusion,
which are largely hypothetical and/or poorly characterized,
fall collectively under the umbrella of the “open artery
hypothesis” (2). Despite a lack of consensus, late mechanical
reperfusion after MI seems to be a common treatment
strategy.
Clinical interest in the open artery hypothesis (3)
stemmed from sub-group analyses demonstrating apprecia-
ble survival, compared with placebo-matched controls, in
patients with MI receiving streptokinase 12 h after symp-
tom onset (1,4). Subsequent thrombolytic studies powered
specifically to address the role of late reperfusion, however,
failed to confirm these initial observations (5). More re-
cently, interest in the open artery hypothesis has resurfaced
as safer and more effective mechanical revascularization
practices have emerged. Although observational data sug-
gest a role for late intervention (6), the results of random-
ized trials are inconclusive (7–9). One recent trial (10),
however (albeit with incomplete follow-up and relatively
high rates of restenosis), has shown long-term clinical
benefits from balloon angioplasty late after MI and thus
suggests that late-presenting patients, or those with failed
thrombolysis, may still benefit from percutaneous coronary
intervention (PCI) by mechanisms independent of myocar-
dial salvage.
We therefore addressed this issue by conducting a pro-
spective randomized trial comparing medical therapy with
late PCI (including stents) in symptom-free patients with
LV dysfunction after anterior MI associated with a proximal
occlusion of the left anterior descending (LAD) coronary
artery.
METHODS
The Open Artery Trial protocol is shown in Figure 1.
From the *Department of Cardiology, Kings College London; †The Rayne
Institute, ‡Guys and St Thomas’ Hospitals, London, and the §Department of
Cardiology, Eastbourne District General Hospital, Eastbourne, United Kingdom.
This study was supported by the British Heart Foundation (BHF PG 97051). Stents
were provided gratis by Boston Scientific.
Manuscript received December 10, 2001; revised manuscript received May 2, 2002,
accepted May 24, 2002.
Journal of the American College of Cardiology Vol. 40, No. 5, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)02058-2
Patient selection. Patients presenting to a recruitment
center between March 1997 and June 1999 with an acute
transmural anterior wall MI were enrolled. Selection criteria
included the following: 1) age 75 years; 2) an uncompli-
cated hospital course, including absence of post-infarction
angina or cardiogenic shock; 3) sinus rhythm without
bundle branch block; 4) echo-derived ejection fraction
50%, or 3 pathological Q waves in the precordial ECG
leads; and 5) absence of chest pain, ECG change, or
hemodynamic disturbance during modified Bruce treadmill
exercise test. Written informed consent and subsequent
procedures were approved by our Institute’s ethical commit-
tee.
Screening coronary angiography. Coronary angiography
was performed between three days and four weeks of MI
using standard Judkins technique. Patients with an occluded
LAD coronary artery (Thrombolysis In Myocardial Infarc-
tion [TIMI] flow grades 0 or 1) (11) and non-significant
disease elsewhere (50% stenosis) were randomized.
Randomization. Patients were assigned to either medical
therapy alone (closed artery group) or PCI plus stent to the
LAD artery in addition to medical therapy (open artery
group). Randomization was performed with customized
software (MINIM shareware; S.J. Evans et al; The London
Hospital Medical School, London, UK) with matching for
six pre-defined variables likely to influence remodeling: 1)
age (50 or 50 years); 2) gender (male or female); 3)
systolic blood pressure (100 or 100 mm Hg); 4) use of
oral beta-adrenergic blocker therapy; 5) use of angiotensin-
converting enzyme inhibitor (ACE-I) therapy; and 6) LV
end-systolic volume (ESV) (60, 61 to 80, 81 to 100, or
101 ml).
Percutaneous coronary intervention. These procedures
were performed using standard techniques, either at the
time of or within two weeks of angiography (overall between
three days and six weeks of MI). NIR stents (Boston
Scientific Corporation; Quincy, Massachusetts) were rec-
ommended, although selection of guidewires, balloons,
inflation pressures, stent sizes, and use of adjunctive thera-
pies were left to the discretion of the operator. Angiographic
success was defined as the restoration of TIMI flow grades
2 or 3 in the infarct artery together with 50% residual
stenosis. Post-procedural quantitative coronary angio-
graphic assessments were performed off-line with commer-
cial software (Quantim systems, Quinton, Seattle).
Medical treatment after randomization. Optimal medical
therapy for all patients included drugs known to carry
prognostic benefits after MI: 1) aspirin; 2) beta-blockers; 3)
ACE-I; and 4) lipid-lowering agents to maintain total
cholesterol level 4.8 mmol/l. In addition, stented patients
received clopidogrel and higher-dose aspirin for two weeks
post procedure.
Patient follow-up. Patients presented at six weeks, three
months, six months, and 12 months post MI for echocar-
diographic estimates of LV size and function and for
assessments of exercise tolerance and quality of life (QoL).
In addition, at the final 12-month visit, repeated coronary
angiography was performed to re-assess coronary artery
patency.
LEFT VENTRICULAR FUNCTION. Left ventricular function
was assessed by echocardiography (Hewlett Packard sonos
2500 or Advanced Technology Ltd HDI 3000). Estimates
of LV ESV, end-diastolic volume (EDV), and ejection
fraction (EF) were obtained from the average of three
consecutive cardiac cycles taken from apical four chamber
views using the modified Simpson’s rule. Measurements
were performed off-line (VingMed system 5 with in-built
analysis pack) by two blinded echocardiographers after
calibrating for each study. Final values for LV ESV, EDV,
and EF represent the mean of the values of the two
independent reporters.
EXERCISE TOLERANCE. Patients underwent maximal tread-
mill testing using the Bruce protocol. Tests were conducted
by a blinded technician who recorded exercise duration
(min) and maximal cardiac workload (peak rate pressure
product; mm Hg/min).
QOL. A generic QoL tool, the Nottingham Health Profile
(NHP), was self-administered (12).
Study end-points and sample size calculations. Left ven-
tricular ESV is a sensitive measure of post-infarction LV
remodeling and one of the most powerful predictors of
long-term prognosis after MI (13). Furthermore, attenua-
tion of post-infarction LV dilation is thought to be an
important contributing mechanism to the open artery hy-
pothesis (2). The Open Artery Trial was therefore designed
to compare LV ESV between the two study groups of
patients at highest risk of adverse LV remodeling (transmu-
ral anterior MI).
To date, two prospective randomized trials examining the
open artery hypothesis have reported serial changes in LV
ESV (9,10). Data from the former study were available for
the present power calculations. In addition, a Medline
search identified eight observational studies reporting rela-
tionships between infarct artery patency and subsequent LV
ESV (14–21). Using the formula for the comparison of two
Abbreviations and Acronyms
ACE-I  angiotensin-converting enzyme inhibitor
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LAD  left anterior descending
LV  left ventricle/ventricular
MI  myocardial infarction
NHP  Nottingham Health Profile
PCI  percutaneous coronary intervention
QoL  quality of life
TAMI  Thrombolysis and Angioplasty in Myocardial
Infarction trial
TIMI  Thrombolysis In Myocardial Infarction
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means (unpaired data), sample sizes were calculated on the
basis of: 1) an anticipated 30% reduction of LV ESV at 12
months in the open artery group; 2) the statistical signifi-
cance of 0.05; and 3) a power of 80%. Sample size estimates
of 58 patients (weighted mean of observational studies) and
54 patients (randomized study) were calculated. The larger
estimate was used in the design of the present study.
Statistical analysis. Data (mean  SD) were analyzed on
an intention-to-treat basis using SigmaStat v2.03 (incorpo-
rating SPSS). After data passed normality and equal vari-
ance tests, two-way repeated measures analyses of variance
were applied to determine differences in end points by time
post MI and study group allocation. Post hoc Tukey tests
were used to compare between-group differences at six
weeks and 12 months post MI. Non-parametric data were
compared with the Fisher exact test. A p value 0.05 was
considered statistically significant.
RESULTS
Patient recruitment and baseline characteristics. Over
the 28-month recruitment period, 223 patients meeting the
selection criteria were referred for angiography (Fig. 1).
Baseline characteristics (Table 1) of randomized patients
Figure 1. The open artery trial protocol. *Two patients meeting the angiographic criteria were excluded on account of distal left anterior descending (LAD)
occlusion with target vessel diameter 2.5 mm. †Randomization was based on the principle of minimization of confounding baseline variables (see text).
MI  myocardial infarction; PCI  percutaneous coronary intervention; TOAT  Open Artery Trial.
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were similar apart from a trend toward a higher prevalence
of diabetes in the open artery group.
All patients enrolled in the study received, and tolerated,
lisinopril, 10 mg/day. Twenty-six patients in the open group
and 29 in the closed group were given beta-adrenoceptor
blockers in the form of atenolol. At six weeks, the resting
heart rate and systolic and diastolic blood pressures in the
open and closed group were, respectively, 72.7 13.3 versus
74.8  10.2 beats/min, p  0.5; 129.9  18.5 versus 127.6
 16.5 mm Hg, p 0.6; and 78.9 11.9 versus 77.3 9.0
mm Hg, p  0.5.
Results of intervention. Results of PCI are given in Table
2. The procedure was successful in 30 patients (94%). In one
patient, the lesion could not be crossed, while in the other,
a highly calcific lesion precluded stent implantation, al-
though the angioplasty itself was successful. There was one
procedural adverse event with re-infarction occurring 18 h
after intervention. Repeated angiography confirmed stent
thrombosis that was successfully treated with an infusion of
a platelet GPIIb/IIIa receptor antagonist and repeated
angioplasty to the occluded segment.
Follow-up angiography. Patients underwent follow-up
angiography 52.9  4.7 weeks post randomization. Re-
occlusion (TIMI grades 0 or 1 flow) occurred in three
(11.1%) and restenosis (50% diameter stenosis) in five
(18.5%) patients. In addition, spontaneous recanalization
(TIMI 2 flow) occurred in six (18.6%) patients random-
ized to the closed artery group (Table 2).
Left ventricular size and function. Left ventricular ESV,
EDV, and EF were similar in closed and open artery groups
six weeks post MI (Fig. 2). No significant changes in ESV
were observed in the closed artery group over 12 months
(p  0.46), while over the same period, LV ESV signifi-
cantly increased in the open artery group (p  0.01).
Furthermore, at 12 months, LV ESV was significantly
greater in the open artery group than in the closed artery
group (p  0.01).
Exercise tolerance. At six weeks, there were no significant
differences in exercise duration between the closed and open
artery groups (Fig. 3). Over the follow-up period, exercise
duration significantly increased in both groups, but this was
greatest in the open group.
Quality of life. No significant differences between the two
groups were observed at six weeks (Fig. 4). The NHP part
I scores (reflecting self-perceived QoL) significantly in-
creased over time in the closed artery group (p  0.01) and
remained unchanged in the open artery group. The differ-
ence in the two groups at 12 months, however, was not
significant. The NHP part II scores (reflecting impact on
lifestyle) tended to increase (closed artery) and decrease
(open artery) over time. At 12 months, late intervention was
associated with significantly less functional impairment.
Clinical events. The clinical events are described in Table
3. The two deaths in the open artery group occurred
between six and eight months post MI; both were sudden,
with no definite underlying cause identified at post-mortem
examination. The death in the closed artery group occurred
three months post MI and was due to progressive arterial
disease being immediately preceded by re-infarction, stroke,
and circulatory failure. Of the three re-infarctions in the
open artery group, one was related to the percutaneous
transluminal coronary angioplasty procedure and the other
two occurred six to eight weeks post procedure. Electrocar-
diographically, all were in the LAD territory, and repeated
Table 1. Baseline Characteristics of Randomized Patients
Closed Artery
(n  34)
Open Artery
(n  32) p Value
Age (mean  SD), yrs 57.6  11.2 59.1  9.7 0.6
% male 80% 81% 0.9
% thrombolysed 97% 97% 1.3
Peak CK 1,796 1,979 0.5
Risk factors
Diabetes 9% 19% 0.1
Hypertension 32% 28% 0.6
Prior dyslipidemia 18% 28% 0.1
Smoker at time of MI 47% 41% 0.5
Post-MI treatment
Beta-blockers 82% 84% 0.9
ACE-I 100% 100%
Post-MI LV ESV
(pre-intervention)
60 ml 24% 25%
61–80 ml 29% 31%
81–100 ml 15% 13%
0.8
101 ml 32% 31%
Screening angiogram
MI angiogram (days) 29.1  18.0 24.1  17.6 0.3
TIMI 0 flow 77% 72%
TIMI 1 flow 23% 28%
LV end-diastolic pressure
(mm Hg)
26 24 0.4
ACE-I  angiotensin-converting enzyme inhibitor; CK  creatine kinase; ESV 
end-systolic volume; MI  myocardial infarction; LV  left ventricle; TIMI 
Thrombolysis In Myocardial Infarction.
}
Table 2. Percutaneous Intervention
Time From MI
to Procedure (Days)
Reference
Vessel (mm)
MLD
(mm)
Diameter
Stenosis (%)
TIMI Grade Flow (%)
0 1 2 3
Post-PTCA/stent* (n  32) 26.3  17.6 2.7  0.6 2.3  0.5 14.8  10.0 0 3.1 6.3 90.6
Follow-up angiogram
Closed (n  32) 375  32 2.5  0.8 0.5  0.1 77.4  7.1 62.5 18.6 18.6 0
Open (n  27) 365  34 2.9  0.5 2.0  0.7 29.6  23.3 11.1 0 18.5 70.4
*3-mm stents were used in most cases (67%), 3.5-mm stents in 30%, and 2.5-mm stents in 3%. Average stent length was 21.5  5.7 cm (mean  SD).
MI  myocardial infarction; MLD  minimum lumen diameter; PTCA  percutaneous transluminal coronary angioplasty; TIMI  Thrombolysis In Myocardial Infarction.
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angiography demonstrated stent occlusion. The five urgent
revascularizations in the open group were due to re-
infarction (3 cases; see above) and aneurysmal dilatation of
the LV (2 patients; 1 complicated by non-sustained ven-
tricular tachycardia and 1 by severe progressive heart fail-
ure). Elective revascularization was recommended in two
open artery patients, as angiography at 12 months demon-
strated severe in-stent restenosis (left main stem involve-
ment in one case), and in three closed artery patients
(prognostic indications).
Overall, there were 17 clinical events in the open artery
group and 12 in the closed artery group, representing a 42%
increase in the risk of the combined clinical event after
delayed intervention (p  0.05). When data were analyzed
with respect to the first clinical event, there were 13 events
in the open group and nine in the closed group, representing
a 44% relative increase in the risk of a major adverse event
after intervention (p  0.052).
DISCUSSION
We have demonstrated that while late intervention to open
occluded infarct-related arteries in patients after transmural
anterior MI is technically feasible, this strategy is associated
with significantly greater LV dilation than a non-invasive
strategy. The strategy of late intervention, however, may
lead to an improved QoL and increased exercise tolerance.
Our results contrast with an earlier report in similar
patients showing significantly reduced clinical events and
beneficial effects on LV function after late PCI (10). Of
note, however, other larger studies comparing late interven-
tion with conservative management in patients after MI
have not demonstrated superiority of either strategy with
respect to clinical outcome (7,22). Furthermore, our results
are consistent with those of Thrombolysis and Angioplasty
in Myocardial Infarction (TAMI-6) trial in which, although
no significant differences in LV ESV at six months were
observed between patients undergoing late PCI and patients
Figure 2. Left ventricular size and function. Serial changes in left ventricular end-systolic volume, end-diastolic volume, and ejection fraction after
myocardial infarction are shown with respect to patients randomized to the open artery group (open circles; n  28) and to the closed artery group (open
squares; n  33).
Figure 3. Exercise tolerance. Serial changes in maximal exercise duration (min) on the Bruce exercise protocol and peak rate-pressure product (product of
heart rate and systolic blood pressure at point of peak exertion) after myocardial infarction are shown with respect to patients allocated to the open artery
group (open circles; n  26) and to the closed artery group (open squares; n  27).
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treated medically, absolute ESV increased by 9% in the
interventional group and decreased by 13% in the medical
group (9).
During follow-up, the incidence of five pre-defined
clinical events was also recorded in the current study as part
of a secondary efficacy measure. Table 3 illustrates the
combined clinical events. Our combined event rate also
favors a policy of conservative therapy, with a 44% increased
risk of suffering an adverse event in patients undergoing late
PCI.
Of the three re-infarctions in the open artery group, one
was directly related to the interventional procedure, and the
other two occurred six and eight weeks after intervention.
Mechanisms other than sub-acute stent thrombosis (e.g.,
regression of pre-existing collateral vessels) may therefore
underlie these events (see description under possible adverse
effects) (23). The two sudden deaths in the open artery
group (six and eight months after MI) are attributed to
arrhythmic causes. Although late reperfusion has been
shown to favorably alter the arrhythmic substrate with
respect to the prevalence of ventricular late potentials (24),
there is also the possibility that late reperfusion may
promote a pro-arrhythmic environment by maintaining
islands of viable cells within a fibrotic scar (25). This
remains an important clinical issue in need of further
investigation.
Timing of late reperfusion may be an important factor.
Pfisterer et al. (26), for example, reported significant atten-
uation of LV dilation in patients undergoing intervention
two to three weeks after MI but not in patients undergoing
the same procedure three months later. One-third of pa-
tients in the present study underwent PCI between 3 and 7
days of MI, while in another one-third it was between 36
and 42 days. The LV ESV changes between 6 weeks and 12
months of MI in the two sub-groups, however, were similar.
Thus, in the present study, neither the direction nor the
amplitude of the changes in LV ESV was dependent on the
timing of PCI. However, since PCI was not performed in
the first three days after MI, we cannot rule out the presence
of an early time-dependent benefit.
Possible adverse effects of late PCI after MI. There is
increasing evidence that after a large MI, the distal micro-
circulation has a high resistance, leading to low-reflow and
stasis within the epicardial vessel (27). Thus, an occluded
infarct-related artery may indicate high microvascular resis-
tance. Intervention in this situation would therefore not be
expected to carry any appreciable benefits. A similar expla-
nation may explain the lack of advantage of fibrinolytics in
combination with IIb/IIIa receptor blockers over fibrinolyt-
ics alone, despite a markedly higher prevalence of infarct
artery patency (28).
In the setting of an occluded infarct vessel, distal ischemic
myocardium is often supported by collateral vessels. After
intervention, collateral vessels may become embolized, and
this may be one mechanism contributing to the documented
and rapid regression of recruitable collateral support after
PCI for total occlusions (23). Interestingly, the two open
artery patients in our study who had re-infarctions six to
Figure 4. Quality of life. Serial changes in quality of life scores (as assessed
by the Nottingham Health Profile [NHP]) after myocardial infarction are
shown. Higher scores reflect poorer quality of life. The NHP part I scores
(reflecting self-perceived quality of life) are represented by open circles (n
 30) for open artery patients and open squares (n  33) for closed artery
patients. The NHP part II scores (reflecting overall impact on lifestyle) are
represented by closed circles for open artery patients (n  30) and closed
squares (n  33) for closed artery patients.
Table 3. Clinical Events
First Event Only All Events
Closed Artery
(n  34)
Open Artery
(n  32)
Closed Artery
(n  34)
Open Artery
(n  32)
Death 0 (0%) 1 (3.1%) 1 (2.9%) 2 (6.3%)
Myocardial infarction 1 (2.9%) 3 (9.4%) 1 (2.9%) 3 (9.4%)
Stroke 0 (0%) 1 (3.1%) 1 (2.9%) 1 (3.1%)
Heart failure 6 (17.7%) 4 (12.5%) 6 (17.7%) 4 (12.5%)
Revascularization (all) 2 (5.9%) 4 (12.5%) 3 (8.8%) 7 (21.9%)
Revascularization (urgent) 0 (0%) 2 (6.3%) 0 (0%) 5 (15.6%)
Revascularization (elective) 2 (5.9%) 2 (6.3%) 3 (8.8%) 2 (6.3%)
Combined event rate* 9 (26.5%) 13 (40.6)† 12 (35.3%) 17 (53.1)‡
Risk increase (%) 44% 42%
*Combined event rate represents the composite rate of death, myocardial infarction, stroke, heart failure, and need for
revascularization (all). †p  0.05 (open group vs. closed group). ‡p  0.02 (open group vs. closed group).
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eight weeks after PCI were found to have well developed
collateral vessels at the time of their initial intervention
(Rentrop grades 2 and 3, respectively). Angiography shortly
after re-occlusion, however, failed to show significant col-
lateral support.
Medical treatment in the two study groups was standard-
ized. After stent deployment, however, patients received
clopidogrel together with high-dose aspirin for two weeks.
An adverse remodeling effect from increased anti-
inflammatory activity in the open artery patients cannot be
excluded (29,30), but seems unlikely, given the known
benefits of this combination (31).
QoL and exercise tolerance after late intervention.
Despite our findings of significant LV dilation in patients
treated with late intervention, QoL and exercise tolerance
either tended to, or actually, improved in these patients. The
NHP is a sensitive tool that has been validated for use in
patients with cardiovascular disease. Previously, for exam-
ple, it was utilized to compare angioplasty with surgery in
patients with coronary artery disease, in which both invasive
strategies were shown to result in improved QoL (32). More
recently, in a thrombolytic study, health-related QoL was
assessed in more than 1,800 patients by telephone interview
using a combination of various questionnaires. Interestingly,
health-related QoL was found to relate to early LV ejection
fraction (myocardial salvage), but not infarct artery patency
(33).
Study limitations. Our study has several limitations. First,
this is a small study powered to compare only LV ESV.
Second, echocardiographic estimates of LV volume post MI
are disturbed by various assumptions. Third, although
micro-embolization may represent a potential mechanism
that contributed to the lack of benefit in the open artery
group, we did not formally assess the extent of peri-
procedural micro-infarction by routine measurement of
cardiac enzymes. Fourth, although we excluded patients
with a positive exercise test early after MI, we cannot
exclude a selection bias in terms of residual myocardial
viability. Fifth, as evidenced by the exclusion in Figure 1,
our study population was highly selected, limiting the
generalizability of our findings. Finally, the role of the
micro-vascular circulation is inadequately addressed. Future
studies combining the use of platelet IIb/IIIa receptor
antagonists and pressure wires may help clarify this issue.
Clinical implications. Observational data show that sus-
tained infarct artery patency after MI confers long-term
benefits. Our study, however, demonstrates that although
late intervention after MI is technically feasible, in our
highly selected patient group, it is associated with significant
LV dilation compared with medical therapy. Thus, patients
remaining symptom-free after MI may not derive objective
benefits from late mechanical revascularization. If such
procedures are considered in this patient group, they should
be within the context of ongoing clinical trials.
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